Related Experiment Video
Updated: Nov 4, 2025
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line
Andrew J Rong1, Ryan A Gallo2, Michelle G Zhang2,3
1Department of Oculoplastic Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Purpose:
Sebaceous carcinoma (SC) is a malignant eyelid tumor of the ocular adnexa that is primarily treated via surgical excision. Few therapies exist in advanced cases, and medical therapy is limited because of our incomplete understanding of SC biology. Herein, we describe a technique to culture human ocular adnexal SC for use as an in vitro model.
Methods:
Human ocular adnexal SC tumor cells were isolated from a patient undergoing orbital exenteration surgery and named Bascom Palmer 50 (BP50). They were cultured in Dulbecco's modified Eagle medium/nutrient mixture F-12 supplemented with 10% fetal bovine serum and antibiotics and were maintained at 37°C in humidified 5% CO2. The cells were characterized by immunohistochemistry, exome sequencing, and short tandem repeats analysis. In vitro drug screening against mitomycin-C (MMC) was performed using a cell viability assay.
Results:
BP50 grew past 40 passages with a doubling time of 52.3 hours. Immunocytochemical staining revealed expression of SC-associated markers adipophilin, epithelial membrane antigen, p53, and androgen receptor. Whole exome sequencing showed a significant carryover in somatic mutations between the tumor tissue and corresponding cell line, revealing genetic markers consistent with SC. MMC affected cell viability in a dose-dependent manner.
Conclusions:
BP50 displays characteristics of ocular adnexal SC and therefore may facilitate improved understanding of SC biology and the high throughput assessment of novel therapeutic compounds and new drug combinatorial approaches targeted for this disease.
Translational Relevance:
Drug screening with MMC against these cells shows in vitro evidence to support its continued clinical use in SC.
Insights
Researchers developed a new cell model for sebaceous carcinoma (SC), an eyelid cancer. This model, BP50, allows for better understanding of SC biology and testing new treatments, including mitomycin-C.
Area of Science:
- Ophthalmology
- Oncology
- Cell Biology
Background:
- Sebaceous carcinoma (SC) is a rare but aggressive malignant eyelid tumor.
- Current treatment options for advanced SC are limited due to incomplete understanding of its biology.
- There is a need for reliable in vitro models to study SC and develop new therapies.
Purpose of the Study:
- To establish and characterize a novel human ocular adnexal sebaceous carcinoma cell line for in vitro research.
- To create a platform for high-throughput screening of potential therapeutic compounds against SC.
- To investigate the efficacy of existing drugs, such as mitomycin-C, in an in vitro SC model.
Main Methods:
- Isolation and culture of human ocular adnexal SC tumor cells (BP50).
- Characterization of the cell line using immunocytochemistry, exome sequencing, and short tandem repeats analysis.
- In vitro drug screening using a cell viability assay to assess response to mitomycin-C.
Main Results:
- The BP50 cell line demonstrated stable growth and maintained SC-associated marker expression through multiple passages.
- Exome sequencing confirmed genetic similarities between the tumor tissue and the BP50 cell line.
- Mitomycin-C exhibited a dose-dependent effect on BP50 cell viability.
Conclusions:
- The BP50 cell line accurately represents ocular adnexal SC, serving as a valuable tool for biological studies.
- This model facilitates the assessment of novel therapeutic agents and drug combinations for SC treatment.
- In vitro results support the continued clinical application of mitomycin-C for sebaceous carcinoma.
More Related Videos
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022